These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1666923)

  • 1. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC.
    Tashkin DP; Gliederer F; Rose J; Change P; Hui KK; Yu JL; Wu TC
    Pharmacol Biochem Behav; 1991 Nov; 40(3):651-6. PubMed ID: 1666923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette.
    Tashkin DP; Gliederer F; Rose J; Chang P; Hui KK; Yu JL; Wu TC
    Pharmacol Biochem Behav; 1991 Nov; 40(3):657-61. PubMed ID: 1666924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking.
    Matthias P; Tashkin DP; Marques-Magallanes JA; Wilkins JN; Simmons MS
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1145-50. PubMed ID: 9408226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hazards of smoking marijuana as compared with tobacco.
    Wu TC; Tashkin DP; Djahed B; Rose JE
    N Engl J Med; 1988 Feb; 318(6):347-51. PubMed ID: 3340105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
    Azorlosa JL; Heishman SJ; Stitzer ML; Mahaffey JM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):114-22. PubMed ID: 1313866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marijuana smoking: effects of varying puff volume and breathhold duration.
    Azorlosa JL; Greenwald MK; Stitzer ML
    J Pharmacol Exp Ther; 1995 Feb; 272(2):560-9. PubMed ID: 7853169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marijuana's dose-dependent effects in daily marijuana smokers.
    Ramesh D; Haney M; Cooper ZD
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-9-tetrahydrocannabinol content and human marijuana self-administration.
    Chait LD
    Psychopharmacology (Berl); 1989; 98(1):51-5. PubMed ID: 2543018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.
    Cooper ZD; Haney M
    Drug Alcohol Depend; 2009 Aug; 103(3):107-13. PubMed ID: 19443132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate.
    Menkes DB; Howard RC; Spears GF; Cairns ER
    Psychopharmacology (Berl); 1991; 103(2):277-9. PubMed ID: 1851311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to marijuana as a function of potency and breathhold duration.
    Zacny JP; Chait LD
    Psychopharmacology (Berl); 1991; 103(2):223-6. PubMed ID: 2027922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrocannabinol content and differences in marijuana smoking behavior.
    Herning RI; Hooker WD; Jones RT
    Psychopharmacology (Berl); 1986; 90(2):160-2. PubMed ID: 3024196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
    Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacologic effects of daily marijuana smoking in humans.
    Perez-Reyes M; White WR; McDonald SA; Hicks RE; Jeffcoat AR; Cook CE
    Pharmacol Biochem Behav; 1991 Nov; 40(3):691-4. PubMed ID: 1666929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
    Heishman SJ; Stitzer ML; Yingling JE
    Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers.
    Cronenberger C; Mould DR; Roethig HJ; Sarkar M
    Br J Clin Pharmacol; 2008 Jan; 65(1):30-9. PubMed ID: 17764477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.
    Chait LD; Zacny JP
    Psychopharmacology (Berl); 1992; 107(2-3):255-62. PubMed ID: 1319601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
    Greenwald MK; Stitzer ML
    Drug Alcohol Depend; 2000 Jun; 59(3):261-75. PubMed ID: 10812286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the absorption phase of marijuana smoking.
    Huestis MA; Sampson AH; Holicky BJ; Henningfield JE; Cone EJ
    Clin Pharmacol Ther; 1992 Jul; 52(1):31-41. PubMed ID: 1320536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.